Loading clinical trials...

COMPLETEDPhase 1NCT02673567

To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

This is a single center, randomized, double-blind, placebo-controlled study to assess the pharmacokinetics, safety, and tolerability of subcutaneous administration of TEV-48125 (single ascending doses...

Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 4

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

NCT07052162 · Pharmacokinetics of Tafenoquine

RECRUITING

PK/PD of Caspofungin in Children Severe Infection

NCT04961593 · Pharmacokinetics, Infection, Fungal

RECRUITING

Antibiotic Dosing in Pediatric Intensive Care

NCT02456974 · Pharmacokinetics, Amoxicillin-clavulanate, and more

RECRUITINGNA

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

NCT06426836 · Pharmacokinetics, Amoxicillin-clavulanate, and more

RECRUITINGPhase 1

Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.

NCT06752122 · Healthy Volunteers, Safety, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 13, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment64

Start dateMar 2016

Last updatedDec 13, 2021

Condition

Pharmacokinetics

Locations shown

Teva Investigational Site 13529

Glendale, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 13, 2021Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions